Conventional, High-Intensity Laser, and Magnetic Field Therapies in Carpal Tunnel Syndrome

July 13, 2026 updated by: KTO Karatay University

Comparative Effectiveness of Conventional, High-Intensity Laser, and Magnetic Field Therapies in Carpal Tunnel Syndrome: A Retrospective Study

This retrospective study aims to compare the clinical effectiveness of conventional physical therapy, high-intensity laser therapy (HILT), and pulsed magnetic field therapy (PMFT) in individuals with carpal tunnel syndrome (CTS). The study evaluates changes in pain, symptom severity, functional status, hand grip strength, and electrophysiological findings following treatment. Researchers will compare the outcomes of the three treatment approaches to determine whether HILT or PMFT provides additional clinical benefits beyond conventional therapy. The findings may help clinicians select the most appropriate conservative treatment strategy for patients with CTS.

Study Overview

Detailed Description

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy and is characterized by pain, numbness, tingling, weakness, and functional limitations resulting from compression of the median nerve at the wrist. Conservative treatment is recommended for patients with mild-to-moderate CTS and commonly includes physical therapy modalities. Although conventional physiotherapy remains a standard treatment approach, newer modalities such as high-intensity laser therapy (HILT) and pulsed magnetic field therapy (PMFT) have gained increasing attention because of their potential analgesic, anti-inflammatory, and tissue-healing effects.

This retrospective observational study evaluates and compares the clinical outcomes of patients with CTS who received one of three conservative treatment approaches: conventional physical therapy alone, conventional physical therapy combined with HILT, or conventional physical therapy combined with PMFT. Clinical records will be reviewed to assess treatment-related changes in pain intensity, symptom severity, functional status, hand grip strength, and electrophysiological parameters before and after treatment.

The primary objective of the study is to compare the effectiveness of these treatment approaches in improving clinical outcomes in patients with CTS. The findings are expected to provide evidence regarding the relative effectiveness of HILT and PMFT as adjunctive treatment options to conventional physical therapy and to support clinical decision-making in the conservative management of carpal tunnel syndrome.

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karatay
      • Konya, Karatay, Turkey (Türkiye), 42030
        • Kto Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population included adult patients with mild-to-moderate carpal tunnel syndrome who completed conservative treatment and had complete pre- and post-treatment clinical assessment records. Participants were classified according to the treatment received: conventional physical therapy, conventional physical therapy plus HILT, or conventional physical therapy plus PMFT.

Description

Inclusion Criteria:

  • Diagnosis of carpal tunnel syndrome (CTS)
  • Mild-to-moderate CTS not requiring surgical intervention
  • Positive Tinel's sign
  • Received treatment at the participating center(s) within the past five years
  • Complete pre-treatment and post-treatment clinical assessment records
  • Completion of the prescribed treatment protocol

Exclusion Criteria:

  • Previous carpal tunnel surgery or indication for surgical intervention Incomplete medical records
  • Failure to complete the treatment protocol
  • Presence of concomitant upper extremity disorders that could affect study outcomes
  • Presence of neurological, orthopedic, or systemic conditions that could influence the clinical assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
High-Intensity Laser Therapy (HILT) Group
Participants received high-intensity laser therapy in addition to the conventional physical therapy program.
A standardized conservative treatment program including therapeutic ultrasound, TENS, nerve and tendon gliding exercises, and neutral wrist splinting.
High-intensity laser therapy was applied according to the standard treatment protocol as an adjunct to conventional physical therapy.
Pulsed Magnetic Field Therapy (PMFT) Group
Participants received pulsed magnetic field therapy in addition to the conventional physical therapy program.
A standardized conservative treatment program including therapeutic ultrasound, TENS, nerve and tendon gliding exercises, and neutral wrist splinting.
Pulsed magnetic field therapy was applied according to the standard treatment protocol as an adjunct to conventional physical therapy.
Conventional Physical Therapy Group
Participants received a conventional physical therapy program consisting of therapeutic ultrasound, transcutaneous electrical nerve stimulation (TENS), nerve and tendon gliding exercises, and the use of a neutral wrist splint.
A standardized conservative treatment program including therapeutic ultrasound, TENS, nerve and tendon gliding exercises, and neutral wrist splinting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity
Time Frame: Baseline and immediately after completion of treatment (4 weeks)
Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS), with higher scores indicating greater pain severity.
Baseline and immediately after completion of treatment (4 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand Grip Strength
Time Frame: Baseline and immediately after completion of treatment (4 weeks)
Hand grip strength was measured using a hand dynamometer according to standardized testing procedures. Higher values indicate greater grip strength.
Baseline and immediately after completion of treatment (4 weeks)
Symptom Severity and Functional Status
Time Frame: Baseline and immediately after completion of treatment (4 weeks)
Symptom severity and functional status were evaluated using the Symptom Severity Scale of the Boston Carpal Tunnel Questionnaire. Higher scores indicate more severe symptoms.
Baseline and immediately after completion of treatment (4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2020

Primary Completion (Actual)

October 20, 2024

Study Completion (Actual)

October 20, 2025

Study Registration Dates

First Submitted

July 13, 2026

First Submitted That Met QC Criteria

July 13, 2026

First Posted (Actual)

July 16, 2026

Study Record Updates

Last Update Posted (Actual)

July 16, 2026

Last Update Submitted That Met QC Criteria

July 13, 2026

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the study is based on retrospective medical records, and data sharing is restricted to protect participant confidentiality and comply with institutional and ethical requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome (CTS)

Clinical Trials on Conventional Physical Therapy

Subscribe